Suppr超能文献

机器人辅助经皮冠状动脉介入治疗:一项前瞻性、多中心、随机对照、非劣效性临床试验。

Robot-assisted percutaneous coronary intervention: a prospective, multicenter, randomized controlled, non-inferiority clinical trial.

作者信息

Yu Yi, Chen Zheng, Wang Zhi-Jian, Li Yue-Ping, Yang Li-Xia, Qi Jing, Xie Jing, Huang Tao, Shi Dong-Mei, Zhou Yu-Jie

机构信息

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.

Beijing WeMed Medical Equipment Co., Ltd., Beijing, China.

出版信息

J Geriatr Cardiol. 2025 Aug 28;22(8):725-735. doi: 10.26599/1671-5411.2025.08.008.

Abstract

OBJECTIVE

To evaluate the safety and effectiveness of robot-assisted percutaneous coronary intervention (R-PCI) compared to traditional manual percutaneous coronary intervention (M-PCI).

METHODS

This prospective, multicenter, randomized controlled, non-inferior clinical trial enrolled patients with coronary heart disease who met the inclusion criteria and had indications for elective percutaneous coronary intervention. Participants were randomly assigned to either the R-PCI group or the M-PCI group. Primary endpoints were clinical and technical success rates. Clinical success was defined as visually estimated residual post-percutaneous coronary intervention stenosis < 30% with no 30-day major adverse cardiac events. Technical success in the R-PCI group was defined as successful completion of percutaneous coronary intervention using the ETcath200 robot-assisted system, without conversion to M-PCI in the event of a guidewire or balloon/stent catheter that was unable to cross the vessel or was poorly supported by the catheter. Secondary endpoints included total procedure time, percutaneous coronary intervention procedure time, fluoroscopy time, contrast volume, operator radiation exposure, air kerma, and dose-area product.

RESULTS

The trial enrolled 152 patients (R-PCI: 73 patients, M-PCI: 79 patients). Lesions were predominantly B2/C type (73.6%). Both groups achieved 100% clinical success rate. No major adverse cardiac events occurred during the 30-day follow-up. The R-PCI group had a technical success rate of 100%. The R-PCI group had longer total procedure and fluoroscopy times, but lower operator radiation exposure. The percutaneous coronary intervention procedure time, contrast volume, air kerma, and dose-area product were similar between the two groups.

CONCLUSIONS

For certain complex lesions, performing percutaneous coronary intervention using the ETcath200 robot-assisted system is safe and effective and does not result in conversion to M-PCI.

摘要

目的

评估机器人辅助经皮冠状动脉介入治疗(R-PCI)相较于传统手动经皮冠状动脉介入治疗(M-PCI)的安全性和有效性。

方法

这项前瞻性、多中心、随机对照、非劣效性临床试验纳入了符合纳入标准且有择期经皮冠状动脉介入治疗指征的冠心病患者。参与者被随机分配至R-PCI组或M-PCI组。主要终点为临床成功率和技术成功率。临床成功定义为经皮冠状动脉介入治疗后目测残余狭窄<30%,且无30天内主要不良心脏事件。R-PCI组的技术成功定义为使用ETcath200机器人辅助系统成功完成经皮冠状动脉介入治疗,在导丝或球囊/支架导管无法穿过血管或导管支撑不佳的情况下无需转为M-PCI。次要终点包括总手术时间、经皮冠状动脉介入治疗手术时间、透视时间、造影剂用量、术者辐射暴露、空气比释动能和剂量面积乘积。

结果

该试验纳入了152例患者(R-PCI组:73例患者,M-PCI组:79例患者)。病变主要为B2/C型(73.6%)。两组的临床成功率均达到100%。30天随访期间未发生主要不良心脏事件。R-PCI组的技术成功率为100%。R-PCI组的总手术时间和透视时间更长,但术者辐射暴露更低。两组的经皮冠状动脉介入治疗手术时间、造影剂用量、空气比释动能和剂量面积乘积相似。

结论

对于某些复杂病变,使用ETcath200机器人辅助系统进行经皮冠状动脉介入治疗是安全有效的,且不会导致转为M-PCI。

相似文献

7
Subintimal angioplasty for lower limb arterial chronic total occlusions.内膜下血管成形术治疗下肢动脉慢性完全闭塞病变
Cochrane Database Syst Rev. 2016 Nov 18;11(11):CD009418. doi: 10.1002/14651858.CD009418.pub3.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验